A number of biosimilar products are already in the market in Europe. Following enactment of the Biologics Price Competition and Innovation Act of 2009 (BPCI Act), an abbreviated approval pathway for biosimilars has been created in United States.
What short cut does he see that most other companies can't find.
Market Data 
Markets 
AI
